TSS Receives CDP SME Climate Score 'SME B' for Strong Climate Actions

A technician assembles a temperature data logger.
TSS, a global company specializing in temperature monitoring for the pharmaceutical supply chain, is proud to announce that it has received an 'SME B' rating from the 2024 CDP SME Climate Score. This recognition highlights TSS’s commitment to being open about its environmental impact and taking steps to reduce it.
PRESS RELEASE, 4 March 2025

The CDP SME Climate Score measures how small and medium-sized businesses manage and share their climate-related information. It follows global standards like the Task Force on Climate-Related Financial Disclosures (TCFD) and IFRS S2 Climate-related Disclosures. Earning an 'SME B' score means that TSS has put strong environmental plans in place and is actively working to lower its carbon footprint.

“At TSS, we believe that sustainability is a key part of the pharmaceutical supply chain’s future,” said Lie Berglind, Chief Quality Officer at TSS. “This recognition from CDP shows that we are making real progress in reducing our environmental impact. Our customers can trust that we are committed to building a greener pharma supply chain. By using data-driven solutions, we continue to improve efficiency and cut emissions.”

TSS will keep working on new sustainability efforts, aligning with global climate goals, and helping customers meet their own environmental targets.

__wf_reserved_inherit

About CDP SME Climate Score

CDP is a global non-profit that runs the world’s only independent environmental disclosure system. As the founder of environmental reporting, we believe in transparency and the power of data to drive change. Partnering with leaders in enterprise, capital, policy and science, we surface the information needed to enable Earth-positive decisions. We helped more than 24,800 companies and 1,100 cities, states and regions disclose their environmental impacts in 2024. Financial institutions with more than a quarter of the world’s institutional assets use CDP data to help inform investment and lending decisions. Aligned with the ISSB’s climate standard, IFRS S2, as its foundational baseline, CDP integrates best-practice reporting standards and frameworks in one place. Our team is truly global, united by our shared desire to build a world where people, planet and profit are truly balanced. Visit CDP.net or follow us @CDP to find out more.

About TSS

TSS is a temperature control monitoring and supply chain solutions provider serving the life science and pharmaceutical industry globally. With headquarters in Sweden, TSS have 30 years of experience providing a compliance baseline in hosting GxP Data and GxP validated SaaS to life science companies.

TSS aims to assure safe drugs for every patient by transforming the global pharmaceutical supply chain through an industry leading cloud temperature management solutions. Working in partnership with pharmaceutical companies, TSS provide advanced monitoring and analytics tools to help our client's meet compliance, implement lean and sustainable supply chains, and deliver drugs safely.

Contact

Tobias Holmer
Chief Executive Officer, TSS
tobias.holmer@tss.se

For media inquiries:

Josefin Malmgren
Head of Marketing & Communication, TSS
josefin.malmgren@tss.se

You may also be interested in

Profile photo of Gustaf Rasin, new Chief Operations Officer at TSS.

TSS Welcomes Gustaf Rasin as New Chief Operations Officer

TSS, a prominent provider of temperature monitoring solutions, is delighted to announce the appointment of Gustaf Rasin as its new Chief Operations Officer (COO). Gustaf Rasin will play a vital role in refining the company's operational workflows and fostering its growth and environmental sustainability vision.
Read moreDownload Whitepaper

Making the pharma industry future-proof through supply chain digitalization

Supply chain digitalization, or rather digital transformation, provides a path to sustainable solutions for many of the challenges in managing the pharmaceutical industry’s supply chain such as compliance, traceability, end-to-end visibility, error-reduction, quality assurance and process efficiencies.
Read moreDownload Whitepaper
A doctor and patient in a clinical trial consultation.

How to Scale Up Your Clinical Trials

Pharmaceutical companies are under pressure to bring new drugs to market quickly. This urgency is driven by the needs of patients, requirements from authorities, and investors. Clinical trials are a crucial part of this process, but they can be delayed by manual processes.
Read moreDownload Whitepaper

You may also be interested in

TSS Sponsors the 27th Annual Clinical Trial Supply Europe 2026 in Barcelona

TSS is proud to sponsor the 27th Annual Clinical Trial Supply Europe, taking place 24–25 February 2026 in Barcelona, Spain. The event brings together clinical supply professionals, sponsors, CROs, and solution providers to discuss how to strengthen resilience, quality, and patient safety across the clinical trial supply chain.
Read more

Can You Rely on the Results from Your Clinical Trials?

The success of a clinical trial depends on the reliability of its data. Many investigational drugs are sensitive to temperature, and any temperature deviation can affect their quality and, in the worst case, patient safety. Automated and integrated temperature monitoring solutions help secure data quality, support compliance, and speed up the delivery of new medicines to patients.
Read more

Subscribe to our newsletter

Sign up for our newsletter to receive all the latest TSS news and insights in temperature management solutions.